Payment overview · 2025
General Payments
$67.76
3 reported records · 3 companies
Healthcare provider profile · identity verified
Timothy Scott Johnston, M.D.
Allopathic & Osteopathic Physicians|Family Medicine · MERCED, CA · NPI 1528097847
Verified facts
What the public records show
CMS Open Payments records show Timothy Scott Johnston, M.D. received $67.76 in general payments during 2025 across 3 reported records.
ACADIA Pharmaceuticals Inc accounted for 43.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 5 associated products.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| ACADIA Pharmaceuticals Inc | Unresolved — no canonical attribution shown | $29.12 | 43.0% | 1 | 2025 |
| Hologic Sales and Service, LLC | Unresolved — no canonical attribution shown | $22.82 | 33.7% | 1 | 2025 |
| Merck Sharp & Dohme LLC | Unresolved — no canonical attribution shown | $15.82 | 23.4% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $67.76 | 3 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| DAYBUE Normalized: daybue |
Drug | ACADIA Pharmaceuticals Inc | $29.12 | 1 | 2025 |
Source payment records
|
|||||
| APTIMA Normalized: aptima |
Device | Hologic Sales and Service, LLC | $22.82 | 1 | 2025 |
Source payment records
|
|||||
| THINPREP 2000 PROCESSOR Normalized: thinprep 2000 processor |
Device | Hologic Sales and Service, LLC | $22.82 | 1 | 2025 |
Source payment records
|
|||||
| CAPVAXIVE Normalized: capvaxive |
Biological | Merck Sharp & Dohme LLC | $15.82 | 1 | 2025 |
Source payment records
|
|||||
| M-M-R II Normalized: m m r ii |
Biological | Merck Sharp & Dohme LLC | $15.82 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Levothyroxine Sodium | Levothyroxine Sodium | 419 | 65 |
| Atorvastatin Calcium | Atorvastatin Calcium | 390 | 98 |
| Furosemide | Furosemide | 261 | 48 |
| Metformin Hcl | Metformin Hcl | 250 | 55 |
| Eliquis | Apixaban | 233 | 34 |
| Lisinopril | Lisinopril | 227 | 64 |
| Losartan Potassium | Losartan Potassium | 171 | 45 |
| Gabapentin | Gabapentin | 162 | 36 |
| Amlodipine Besylate | Amlodipine Besylate | 158 | 49 |
| Carvedilol | Carvedilol | 144 | 30 |
| Metoprolol Tartrate | Metoprolol Tartrate | 122 | 28 |
| Potassium Chloride | Potassium Chloride | 121 | 25 |
| Hydrochlorothiazide | Hydrochlorothiazide | 119 | 27 |
| Lactulose | Lactulose | 108 | 15 |
| Omeprazole | Omeprazole | 107 | 39 |
| Tamsulosin Hcl | Tamsulosin Hcl | 105 | 35 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 101 | 26 |
| Lorazepam | Lorazepam | 101 | 26 |
| Alprazolam | Alprazolam | 94 | 18 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 91 | 25 |
| Trazodone Hcl | Trazodone Hcl | 86 | 25 |
| Sertraline Hcl | Sertraline Hcl | 84 | 19 |
| Tramadol Hcl | Tramadol Hcl | 83 | 16 |
| Famotidine | Famotidine | 82 | 26 |
| Glipizide | Glipizide | 81 | 21 |
| Hydralazine Hcl | Hydralazine Hcl | 76 | 19 |
| Olanzapine | Olanzapine | 76 | 16 |
| Simvastatin | Simvastatin | 76 | 19 |
| Clopidogrel | Clopidogrel Bisulfate | 75 | 23 |
| Levetiracetam | Levetiracetam | 74 | 12 |
| Metoprolol Succinate | Metoprolol Succinate | 71 | 22 |
| Xarelto | Rivaroxaban | 67 | suppressed |
| Quetiapine Fumarate | Quetiapine Fumarate | 65 | 15 |
| Montelukast Sodium | Montelukast Sodium | 63 | 19 |
| Citalopram Hbr | Citalopram Hydrobromide | 55 | suppressed |
| Risperidone | Risperidone | 55 | suppressed |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 54 | 11 |
| Clonazepam | Clonazepam | 50 | 14 |
| Fluticasone Propionate | Fluticasone Propionate | 50 | 14 |
| Oxybutynin Chloride | Oxybutynin Chloride | 49 | suppressed |
| Allopurinol | Allopurinol | 48 | 14 |
| Clonidine Hcl | Clonidine Hcl | 48 | 14 |
| Chlorthalidone | Chlorthalidone | 47 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 47 | 25 |
| Januvia | Sitagliptin Phosphate | 45 | suppressed |
| Donepezil Hcl | Donepezil Hcl | 44 | suppressed |
| Pantoprazole Sodium | Pantoprazole Sodium | 43 | 16 |
| Alendronate Sodium | Alendronate Sodium | 42 | 13 |
| Clozapine | Clozapine | 42 | 15 |
| Propranolol Hcl | Propranolol Hcl | 42 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 41 | 12 |
| Atenolol | Atenolol | 40 | 18 |
| Nifedipine Er | Nifedipine | 39 | suppressed |
| Latanoprost | Latanoprost | 38 | suppressed |
| Bumetanide | Bumetanide | 37 | suppressed |
| Valproic Acid | Valproic Acid (As Sodium Salt) | 37 | suppressed |
| Finasteride | Finasteride | 36 | 12 |
| Meloxicam | Meloxicam | 36 | suppressed |
| Mirtazapine | Mirtazapine | 36 | suppressed |
| Baclofen | Baclofen | 35 | suppressed |
| Ozempic | Semaglutide | 35 | suppressed |
| Duloxetine Hcl | Duloxetine Hcl | 34 | suppressed |
| Myrbetriq | Mirabegron | 34 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 34 | suppressed |
| Ivermectin | Ivermectin | 33 | 19 |
| Budesonide | Budesonide | 32 | suppressed |
| Divalproex Sodium | Divalproex Sodium | 32 | suppressed |
| Divalproex Sodium Er | Divalproex Sodium | 31 | suppressed |
| Lithium Carbonate | Lithium Carbonate | 31 | suppressed |
| Glimepiride | Glimepiride | 30 | suppressed |
| Ibuprofen | Ibuprofen | 30 | suppressed |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 29 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 28 | 12 |
| Haloperidol | Haloperidol | 26 | suppressed |
| Jardiance | Empagliflozin | 26 | 12 |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 25 | 18 |
| Buspirone Hcl | Buspirone Hcl | 25 | suppressed |
| Desmopressin Acetate | Desmopressin Acetate | 25 | suppressed |
| Linzess | Linaclotide | 25 | suppressed |
| Nystatin | Nystatin | 25 | 12 |
| Pentoxifylline | Pentoxifylline | 25 | suppressed |
| Perphenazine | Perphenazine | 25 | suppressed |
| Tizanidine Hcl | Tizanidine Hcl | 25 | suppressed |
| Benztropine Mesylate | Benztropine Mesylate | 24 | suppressed |
| Icosapent Ethyl | Icosapent Ethyl | 24 | suppressed |
| Cephalexin | Cephalexin | 23 | 19 |
| Fluoxetine Hcl | Fluoxetine Hcl | 23 | suppressed |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 22 | suppressed |
| Aripiprazole | Aripiprazole | 21 | suppressed |
| Fluphenazine Hcl | Fluphenazine Hcl | 21 | suppressed |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 21 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 21 | 16 |
| Nuedexta | Dextromethorphan Hbr/Quinidine | 21 | suppressed |
| Nystop | Nystatin | 21 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 21 | suppressed |
| Zolpidem Tartrate | Zolpidem Tartrate | 21 | suppressed |
| Celecoxib | Celecoxib | 20 | suppressed |
| Olanzapine Odt | Olanzapine | 20 | suppressed |
| Pravastatin Sodium | Pravastatin Sodium | 20 | suppressed |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 19 | suppressed |
| Humalog | Insulin Lispro | 19 | suppressed |
| Albuterol Sulfate | Albuterol Sulfate | 18 | 12 |
| Breo Ellipta | Fluticasone/Vilanterol | 18 | suppressed |
| Breyna | Budesonide/Formoterol Fumarate | 18 | suppressed |
| Diazepam | Diazepam | 18 | suppressed |
| Oxcarbazepine | Oxcarbazepine | 18 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 18 | suppressed |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 17 | suppressed |
| Brilinta | Ticagrelor | 17 | suppressed |
| Haloperidol Decanoate | Haloperidol Decanoate | 17 | suppressed |
| Pioglitazone Hcl | Pioglitazone Hcl | 17 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 16 | suppressed |
| Carbamazepine | Carbamazepine | 16 | suppressed |
| Fludrocortisone Acetate | Fludrocortisone Acetate | 16 | suppressed |
| Invega Sustenna | Paliperidone Palmitate | 16 | suppressed |
| Pregabalin | Pregabalin | 16 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 15 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 15 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 14 | suppressed |
| Lovastatin | Lovastatin | 14 | suppressed |
| Ondansetron Odt | Ondansetron | 14 | suppressed |
| Prednisone | Prednisone | 14 | suppressed |
| Tolterodine Tartrate Er | Tolterodine Tartrate | 14 | suppressed |
| Warfarin Sodium | Warfarin Sodium | 14 | suppressed |
| Atrovent Hfa | Ipratropium Bromide | 13 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 13 | suppressed |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 13 | suppressed |
| Lamivudine | Lamivudine | 13 | suppressed |
| Nebivolol Hcl | Nebivolol Hcl | 13 | suppressed |
| Tivicay | Dolutegravir Sodium | 13 | suppressed |
| Calcitriol | Calcitriol | 12 | suppressed |
| Naltrexone Hcl | Naltrexone Hcl | 12 | suppressed |
| Ranolazine Er | Ranolazine | 12 | suppressed |
| Risperidone Odt | Risperidone | 12 | suppressed |
| Vancomycin Hcl | Vancomycin Hcl | 12 | suppressed |
| Atropine Sulfate | Atropine Sulfate | 11 | suppressed |
| Azithromycin | Azithromycin | 11 | 11 |
| Enalapril Maleate | Enalapril Maleate | 11 | suppressed |
| Eszopiclone | Eszopiclone | 11 | suppressed |
| Fenofibrate | Fenofibrate | 11 | suppressed |
| Fluticasone-Vilanterol | Fluticasone/Vilanterol | 11 | suppressed |
| Glyburide | Glyburide | 11 | suppressed |
| Lamotrigine | Lamotrigine | 11 | suppressed |
| Metronidazole | Metronidazole | 11 | suppressed |
| Midodrine Hcl | Midodrine Hcl | 11 | suppressed |
| Risperidone Er | Risperidone Microspheres | 11 | suppressed |
| Spironolactone | Spironolactone | 11 | suppressed |
| Topiramate | Topiramate | 11 | suppressed |
| Ziprasidone Hcl | Ziprasidone Hcl | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $67.76 · 3 records | ACADIA Pharmaceuticals Inc | APTIMA, CAPVAXIVE, DAYBUE, M-M-R II, THINPREP 2000 PROCESSOR | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error